![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | ||
Founding Date | Founding Date 2005 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 4235% decrease | Employees 260 |
Valuation ($) | Valuation ($) 131.1 m | Valuation ($) 3.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $190k (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Net income | Net income ($74.1m) (FY, 2025) | Net income ($215.3m) (FY, 2024) |

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company